Risk is proportional to reward.
The almost guaranteed FDA approval of Sofdra, given the minor packaging amendments required, makes me wonder how much approval has already been priced into the announcement?
Makes me think of CYC and the sell down almost as soon as FDA approval. Not saying the same thing will happen with BOT.
Definitely been a hard slog for long termers. Those who’ve held really deserve an good outcome!
Risk is proportional to reward.The almost guaranteed FDA...
-
- There are more pages in this discussion • 875 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
-0.010(2.70%) |
Mkt cap ! $651.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.5¢ | $1.395M | 3.870M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 266249 | 5 |
View Market Depth
| Last trade - 16.10pm 19/08/2024 (20 minute delay) ? |
| BOT (ASX) Chart |